CSI Market
Sign In | Register

Abvc Biopharma Inc (ABVC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ABVC Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Abvc Biopharma Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-1.69
Depreciation & amortization0.01
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.79
Income (Loss) from Equity Method Investments0.03
Fair Value of Assets Acquired0.00
Ecoc Increase Decrease Income From Forgiveness Of Payables And Debt-
Ecoc Loss From Patent Abandonment-
Debt Instrument Decrease Forgiveness-
Increase Decrase Credit Card Payable-
Increase Decrease In Prepayment-
Increase Decrease In Due To Related Party-
Stock Issued During Period Value Share Based Compensation Gross-
Allowance For Inventory Valuations And Obsolescence Loss-
Loss On Investment In Equity Securities-
Government Grant Income-
Operating Lease Right Of Use Asset Amortization Expense0.09
Increase Decrease In Operating Lease Liability-0.08
Income taxes-0.01
Realized Investment Gains (Losses), Total0.00
Increase (Decrease) in Due from Related Parties-0.13
Increase (Decrease) in Due to Related Parties, Total0.00
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-0.01
Increase (Decrease) in Security Deposits0.01
Increase (Decrease) in Prepaid Expense and Other Assets0.10
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.89
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Financial Assets At Fair Value Through Profit Or Loss-
Repayment From Related Parties-
Repayment Of Convertible Notes Payable Related Parties0.76
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments-0.68
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable-0.03
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.05
Financing Activities
Short-term debt Net-0.66
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.10
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.42
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Ecoc Increase Decrease Bank Overdraft-
Fresh Start Adjustment-
Bankruptcy Liquidated Assets-
Fresh Start Adjustments-
Proceeds From Subscription Receivable-
Capital Contribution From Related Parties Under Common Control-
Issuance Of Common Shares For Stockbased Compensation-
Issuance Of Common Stock For Cash-
Net Proceeds From Short Term Borrowings From Third Parties-
Repayment Of Longterm Bank Loans-
Borrowings From Related Parties-
Repayment Of Long Term Bank Loans-
Repayment Of Shortterm Loan-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.34
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.89
Total Cash Flow-1.19
4 historic quarters locked

Sign in to unlock the full Abvc Biopharma Inc cash flow history.

Sign In Create Free Account

About Abvc Biopharma Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-088348

Figures are derived from filed reports and may be restated. Historical data is subject to revision.